Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Active Ingredient: Delavirdine mesylate 100mg equivalent to 82.6mg delavirdine base
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer: Pharmacia & Upjohn Caribe Inc, Arecibo, Puerto Rico
Note: This consent is valid for two years from 1 March 2003.
Dated this 3rd day of April 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).